Occurrence of PARK2 mutations in a never-smoker population with Parkinson's disease in North India

Neuroepidemiology

Volumn 35, Issue 2, 2010, Pages 152-159

  Prabhakar, Sudesh ^a   Vinish, Monika ^a   Das, C P ^a   Anand, Akshay ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Never smokers; PARK2 mutation; Parkinson's disease; Sikhs; Socio economic status

Indexed keywords

PARKIN; PROTEIN PARK2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; SOCIOECONOMICS;

AGE OF ONSET; AGED; DNA; EXONS; FEMALE; GENE DELETION; HUMANS; INDIA; LIFE STYLE; MALE; MIDDLE AGED; MUTATION; PARKINSON DISEASE; POINT MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RELIGION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RURAL POPULATION; SMOKING; SOCIOECONOMIC FACTORS; TISSUE BANKS; UBIQUITIN-PROTEIN LIGASES; URBAN POPULATION;

EID: 77953666070     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000313855     Document Type: Article

References (37)

1. Brooks J, Ding J, Simon-Sanchez J, Paisan- Ruiz C, Singleton AB, Scholz SW: Parkin and PINK1 mutations in early-onset Parkinson's disease: comprehensive screening in publicly available cases and control. J Med Genet 2009; 46: 375-381.
2. Kitada T, Asakawa S, Hattori N, et al: Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998; 392: 605-608. (Pubitemid 28207717)
3. Mayeux R, Marder K, Cote LJ: The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. Am J Epidemiol 1995; 142: 820-827.
4. De Rijk MC, Breteler MM, Graveland GA: Prevalence of Parkinson's disease in the elderly: the Rotterdam Study. Neurology 1995; 45: 2143-2146.
5. Shastry BS: Parkinson disease: etiology, pathogenesis and future of gene therapy. Neurosci Res 2001; 41: 5-12.
6. Kandinov B, Giladi N, Korczyn AD: Smoking and tea consumption delay onset of Parkinson's disease. Parkinsonism Relat Disord 2009; 15: 41-46.
7. Happe S, Baier PC, Helmschmied K, et al: Association of daytime sleepiness with nigrostriatal dopaminergic degeneration in early Parkinson's disease. J Neurol 2007; 254: 1037-1043.
8. Valente EM, Bentivoglio AR, Dixon, PH, et al: Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. Am J Hum Genet 2001; 68: 895-900.
9. Quik M, Huang LZ, Parameswaran N, Bordia T, Campos C, Perez XA: Multiple roles for nicotine in Parkinson's disease. Biochem Pharmacol 2009; 78: 677-685.
10. De Reuck J, De Weweire M, Van Maele G, Santens P: Comparison of age of onset and development of motor complications between smokers and non-smokers in Parkinson's disease. J Neurol Sci 2005; 231: 35-39.
11. Vinish M, Prabhakar S, Khullar M, Verma I, Anand A: Genetic screening reveals high frequency of PARK2. J Neurol Neurosurg Psychiatry 2010; 81: 166-170.
12. Hughes AJ, Daniel SE, Kilford L: Accuracy of the clinical diagnosis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
13. Lang AE, Lozano AM: Parkinson's disease: first of two parts. N Engl J Med 1998; 339: 1044-1053.
14. Jeon BS, Kim JM, Lee DS, et al: An apparently sporadic case with Parkin gene mutation in a Korean woman. Arch Neurol 2001; 58: 988-989.
15. Chaudhary S, Behari M, Dihana M, et al: Parkin mutations in familial and sporadic Parkinson's disease among Indians. Parkinsonism Relat Disord 2006; 12: 239-245.
16. Jindal SK, Aggarwal AN, Chaudhary K, et al: Tobacco smoking in India: prevalence, quitrates and respiratory morbidity. Indian J Chest Dis Allied Sci 2006; 48: 37-42.
17. Wonnacott S, Irons J, Rapier C, Thorne B, Lunt GG: Presynaptic modulation of transmitter release by nicotinic receptors. Prog Brain Res 1989; 79: 157-163.
18. Marshall DL, Redfern PH, Wonnacott S: Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naive and chronic nicotine-treated rats. J Neurochem 1997; 68: 1511-1519.
19. Checkoway H, Nelson LM: Epidemiologic approaches to the study of Parkinson's disease etiology. Epidemiology 1999; 10: 327-336.
20. Strong JA, Dalvi A, Revilla FJ, Sahay A, Samaha FJ, Welge JA, Gong J, Gartner M, Yue X, Yu L: Genotype and smoking history affect risk of levodopa-induced dyskinesias in Parkinson's disease. Mov Disord 2006; 21: 654-659.
21. Hancock DB, Martin ER, Stajich JM, et al: Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease. Arch Neurol 2007; 64: 576-580.
22. Kobayashi T, Wang M, Matsumine H, Hattori N, Kondo T, Mizuno Y: Exonic deletion mutations of parkin gene among sporadic patients with Parkinson's disease. Parkinsonism Relat Disord 2000; 6: 129-131.
23. Lücking CB, Dürr A, Bonifati V, et al: Association between early-onset Parkinson disease and mutations in the parkin gene. N Engl J Med 2000; 342: 1560-1567.
24. Hedrich K, Marder K, Harris J, Kann M, Lynch T, Meija-Santana H, et al: Evaluation of 50 probands with early-onset Parkinson disease for parkin mutations. Neurology 2002; 58: 1239-1246.
25. Periquet M, Latouche M, Lohmann E, et al: Parkin mutations are frequent in patients with isolated early-onset parkinsonism. Brain 2003; 126: 1271-1278.
26. Hattori N, Kitada T, Matsumine H, et al: Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: evidence for variable homozygous deletions in the Parkin gene in affected individuals. Ann Neurol 1998; 44: 935-941.
27. Chen R, Gosavi NS, Langston JW, Chan P: Parkin mutations are rare in patients with young-onset parkinsonism in a US population. Parkinsonism Relat Disord 2003; 9: 309-312.
28. Ozelius LJ, Senthil G, Saunder-Pullman R, et al: LARK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N Engl J Med 2006; 354: 424-425.
29. Kachergus J, Mata IF, Hulihan M, et al: Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. Am J Hum Genet 2005; 76: 672-680.
30. Lesage S, Ibanez P, Lohmann E, et al: G2019S LRRK2 mutation in French and North African families with Parkinson's disease. Ann Neurol 2005; 58: 784-787.
31. Djarmati A, Hedrich K, Svetel M, et al: Detection of Parkin (PARK2) and DJ1 (PARK7) mutations in early-onset Parkinson disease: Parkin mutation frequency depends on ethnic origin of patients. Hum Mutat 2004; 23: 525.
32. Sehmi KS: Patterns and distribution of tobacco consumption in India: impact of religion was not considered. BMJ 2004; 328: 1498-1499.
33. Gatrad R, Jhutti-Johal J, Gill PS, Sheikh A: Sikh birth customs. Arch Dis Child 2005; 90; 560-563.
34. Wooten GF, Currie LJ, Bovbjerg VE, Lee JK, Patrie J: Are men at greater risk for Parkinson's disease than women? J Neurol Neurosurg Psychiatry 2004; 75: 637-639.
35. Lincoln S, Maraganore D, Lesnick T, et al: Parkin variants in North American Parkinson's disease: cases and controls. Mov Disord 2003; 18: 1306-1311.
36. Chien HF, Rohe CF, Costa MD, et al: Earlyonset Parkinson's disease caused by a novel parkin mutation in a genetic isolate from north-eastern Brazil. Neurogenetics 2005: 1-7.
37. Kay DM, Moran D, Moses L, et al: Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients. Ann Neurol 2007; 61: 47-54.